NHI National Health Investors Inc
Price (delayed)
$74.27
Market cap
$3.39B
P/E Ratio
23.65
Dividend/share
$3.6
EPS
$3.14
Enterprise value
$4.51B
Incorporated in 1991, National Health Investors, Inc. is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments.
Highlights
NHI's equity is up by 11% from the previous quarter and by 9% YoY
The net income is up by 9% since the previous quarter
Key stats
What are the main financial stats of NHI
Market
Valuations
Earnings
Shares outstanding
45.69M
Market cap
$3.39B
Enterprise value
$4.51B
Price to earnings (P/E)
23.65
Price to book (P/B)
2.47
Price to sales (P/S)
9.72
EV/EBIT
22.82
EV/EBITDA
16.76
EV/Sales
13.47
Revenue
$335.18M
Gross profit
$292.93M
Operating income
$183.2M
Net income
$137.99M
EBIT
$197.89M
EBITDA
$269.33M
Free cash flow
$56.02M
Per share
Balance sheet
Liquidity
EPS
$3.14
EPS diluted
$3.13
Free cash flow per share
$1.28
Book value per share
$30.08
Revenue per share
$7.64
TBVPS
$59.63
Total assets
$2.61B
Total liabilities
$1.23B
Debt
$1.15B
Equity
$1.37B
Working capital
N/A
Debt to equity
0.84
Current ratio
N/A
Quick ratio
N/A
Net debt/EBITDA
4.16
Margins
Efficiency
Dividend
EBITDA margin
80.4%
Gross margin
87.4%
Net margin
41.2%
Operating margin
54.7%
Return on assets
5.5%
Return on equity
10.8%
Return on invested capital
5.5%
Return on capital employed
N/A
Return on sales
59%
Dividend yield
4.85%
DPS
$3.6
Payout ratio
114.6%
NHI stock price
How has the National Health Investors stock price performed over time
Intraday
0.56%
1 week
0.62%
1 month
3.63%
1 year
20.28%
YTD
7.17%
QTD
0.56%
Financial performance
How have National Health Investors's revenue and profit performed over time
Revenue
$335.18M
Gross profit
$292.93M
Operating income
$183.2M
Net income
$137.99M
Gross margin
87.4%
Net margin
41.2%
The net income is up by 9% since the previous quarter
The net margin has increased by 7% since the previous quarter but it has declined by 2.8% year-on-year
The company's revenue rose by 4.8% YoY
National Health Investors's gross profit has increased by 4.5% YoY
Growth
What is National Health Investors's growth rate over time
Valuation
What is National Health Investors stock price valuation
P/E
23.65
P/B
2.47
P/S
9.72
EV/EBIT
22.82
EV/EBITDA
16.76
EV/Sales
13.47
National Health Investors's EPS has increased by 8% QoQ
NHI's price to book (P/B) is 24% more than its 5-year quarterly average of 2.0
NHI's equity is up by 11% from the previous quarter and by 9% YoY
The stock's P/S is 12% more than its 5-year quarterly average of 8.7 and 3.4% more than its last 4 quarters average of 9.4
The company's revenue rose by 4.8% YoY
Efficiency
How efficient is National Health Investors business performance
The return on assets has increased by 8% since the previous quarter
The ROE has grown by 6% from the previous quarter
The ROIC has increased by 6% since the previous quarter and by 3.8% year-on-year
National Health Investors's return on sales has increased by 4.2% QoQ but it has decreased by 2.6% YoY
Dividends
What is NHI's dividend history
DPS
$3.6
Dividend yield
4.85%
Payout ratio
114.6%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did National Health Investors financials performed over time
The total assets is 113% more than the total liabilities
The total assets has grown by 6% from the previous quarter and by 5% YoY
The debt is 16% smaller than the equity
NHI's equity is up by 11% from the previous quarter and by 9% YoY
The debt to equity has contracted by 9% from the previous quarter and by 8% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.